TipRanks
Advertisement
Advertisement

GDTC Stock Latest News

Cytomed Therapeutics receives noncompliance notification from Nasdaq
The FlyCytomed Therapeutics receives noncompliance notification from Nasdaq
9d ago
GDTC
CytoMed Therapeutics Posts Narrower Interim Loss in June 2026 SEC Filing
PremiumCompany Announcements
CytoMed Therapeutics Posts Narrower Interim Loss in June 2026 SEC Filing
18d ago
6K
GDTC
CytoMed Chairman Boosts Personal Stake and Funds R&D Expansion at LongevityBank
PremiumCompany Announcements
CytoMed Chairman Boosts Personal Stake and Funds R&D Expansion at LongevityBank
4M ago
6K
GDTC
CytoMed Therapeutics Shareholders Approve All Resolutions at May 22 AGM
PremiumCompany Announcements
CytoMed Therapeutics Shareholders Approve All Resolutions at May 22 AGM
5M ago
6K
GDTC
CytoMed Chairman Moves to Boost Personal Stake Through Private Share Purchases
PremiumCompany Announcements
CytoMed Chairman Moves to Boost Personal Stake Through Private Share Purchases
5M ago
6K
GDTC
CytoMed Renames Subsidiary to Drive Asian and International Expansion
PremiumCompany AnnouncementsCytoMed Renames Subsidiary to Drive Asian and International Expansion
5M ago
6K
GDTC
CytoMed Therapeutics Sets May 22, 2026 AGM With Expanded Share-Issuance Mandate on the Table
Premium
Company Announcements
CytoMed Therapeutics Sets May 22, 2026 AGM With Expanded Share-Issuance Mandate on the Table
6M ago
6K
GDTC
CytoMed Therapeutics Widens 2025 Loss as It Accelerates Cell Therapy Trials and Southeast Asia Expansion
Premium
Company Announcements
CytoMed Therapeutics Widens 2025 Loss as It Accelerates Cell Therapy Trials and Southeast Asia Expansion
7M ago
6K
GDTC
CytoMed Therapeutics Refutes Misleading Claims, Confirms Ongoing First-in-Human Trial
PremiumCompany Announcements
CytoMed Therapeutics Refutes Misleading Claims, Confirms Ongoing First-in-Human Trial
9M ago
6K
GDTC
Cytomed Therapeutics refutes ‘misleading’ claims, reaffirms clinical progress
PremiumThe Fly
Cytomed Therapeutics refutes ‘misleading’ claims, reaffirms clinical progress
9M ago
GDTC
CytoMed Therapeutics Outlines 2026 Clinical Plans and Seeks Shareholder Input on Patient-Access Scheme
PremiumCompany Announcements
CytoMed Therapeutics Outlines 2026 Clinical Plans and Seeks Shareholder Input on Patient-Access Scheme
9M ago
6K
GDTC
Cytomed sees ‘enough resources’ to continue activites for ‘at least a year’
PremiumThe Fly
Cytomed sees ‘enough resources’ to continue activites for ‘at least a year’
9M ago
GDTC
CytoMed Therapeutics Partners with Malaysian Hospital for Groundbreaking Cancer Trial
PremiumCompany AnnouncementsCytoMed Therapeutics Partners with Malaysian Hospital for Groundbreaking Cancer Trial
10M ago
6K
GDTC
Cytomed Therapeutics enters into MoU with UMMC
Premium
The Fly
Cytomed Therapeutics enters into MoU with UMMC
10M ago
GDTC
CytoMed completes acquisition of T cell technology of TC BioPharm
Premium
The Fly
CytoMed completes acquisition of T cell technology of TC BioPharm
11M ago
GDTC
CytoMed Therapeutics Finalizes Acquisition of T Cell Technology for Cancer Treatment in China and India
PremiumCompany Announcements
CytoMed Therapeutics Finalizes Acquisition of T Cell Technology for Cancer Treatment in China and India
11M ago
6K
GDTC
Cytomed Therapeutics secures investment for subsidiary LongevityBank
PremiumThe Fly
Cytomed Therapeutics secures investment for subsidiary LongevityBank
12M ago
GDTC
CytoMed Therapeutics Secures Investment and Advances China Strategy
PremiumCompany Announcements
CytoMed Therapeutics Secures Investment and Advances China Strategy
12M ago
6K
GDTC
CytoMed Therapeutics’ ANGELICA Trial: A New Frontier in Cancer Treatment
PremiumCompany Announcements
CytoMed Therapeutics’ ANGELICA Trial: A New Frontier in Cancer Treatment
12M ago
GDTC
CytoMed Therapeutics’ Chairman Boosts Stake Amid Biotherapeutics Growth
PremiumCompany AnnouncementsCytoMed Therapeutics’ Chairman Boosts Stake Amid Biotherapeutics Growth
12M ago
6K
GDTC
Cytomed Therapeutics chairman Peter Choo increases holdings to 21.95%
Premium
The Fly
Cytomed Therapeutics chairman Peter Choo increases holdings to 21.95%
12M ago
GDTC
CytoMed Therapeutics Bids for TC BioPharm’s Assets Amid Strategic Expansion
Premium
Company Announcements
CytoMed Therapeutics Bids for TC BioPharm’s Assets Amid Strategic Expansion
1y ago
6K
GDTC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >